Expert Forum on Genomic Medicine
| Date | 22 - 23 Oct 2018 |
|---|---|
| Location | Centre for Global Dialogue Rüschlikon, Zurich, Switzerland Click to open Google Maps |
Tab navigation
Videos
Presentations
|
Monday, 22 October 2018 |
|
|
18.00 |
Networking reception and dinner for speakers at the Centre for Global Dialogue |
|
Tuesday, 23 October 2018 |
|
|
Event moderation: Séverine Rion Logean, Life & Health R&D Manager, Swiss Re |
|
|
08.00 |
Welcome coffee |
|
08.30 |
Welcome and introduction |
|
Topic |
From science fiction to practice |
|
08.35 |
Building an evidence base for the future of genomic medicine Robert Green, Geneticist, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School |
|
08.55 |
Genome editing: What will the future bring? |
|
09.15 |
(Nearly) 100,000 genomes later: What have we learned? |
|
09.35 |
Polygenic risk scores for risk assessment |
|
09.55 |
Panel discussion on the current status and future of genomic medicine: From early detection to cure Mark Bale, Head of Science Partnerships, Genomics England / Department of Health & Social Care, UK |
|
10.35 |
Coffee break |
|
11.00 |
Workshops Workshop session 1: Personalised medicine in the clinical practice and what it means for insurance Workshop session 2: Is reversal of genetic disease a reality? Risks and opportunities for insurance Workshop session 3: The cost and value of the interpretome Workshop session 4: Polygenic risk scores vs. traditional risk factors in underwriting |
|
12.00 |
Lunch |
|
Topic |
A look at today's practice |
|
13.20 |
Precision medicine: A reality check Stefan Foser, Group International Scientific Director, Roche |
|
13.40 |
The value proposition of genetic testing as an insurance offering Marko Bitenc, Founder and CEO, GenePlanet |
|
14.00 |
Genetics and genomics: A view from daily practice in oncology today and tomorrow Beat Thürlimann, Head of Breast Center, Cantonal Hospital St. Gallen |
|
14.20 |
Potential for genetic information to promote healthier behaviours |
|
14.40 |
Panel discussion on the value proposition in insurance: How to motivate individuals to take action on information gained through genetic testing? Robert Green, Geneticist, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School |
|
15.20 |
Coffee break |
|
15.45 |
Workshops Workshop session 1: The impact of genomic medicine on behaviour and insurance Workshop session 2: Exploring the insurance value proposition of genetic testing Workshop session 3: Challenges and dilemmas in clinical counselling Workshop session 4: Potential for genetic information to promote healthier behaviours |
|
16.50 |
Closing remarks and next steps |
|
17.00 |
End of event |
Resources
Speakers
Mark Bale
Head of Science Partnerships
Genomics England / Department of Health & Social Care, UK
Pietro Biroli
Assistant Professor of Economics
University of Zurich
Marko Bitenc
Founder and CEO
GenePlanet
Yommy Chiu
Senior Product Manager
Public Sector Solutions
Stefan Foser
Group International Scientific Director
Roche
Robert Green
Professor of Medicine
Harvard Medical School
Richard Karlsson Linnér
Postdoctoral Researcher
School of Business and Economics, Vrije Universiteit Amsterdam
Lizzy Lubczanski
Client Solutions Manager L&H UK&I
Globals
Colleen McBride
Rollins Professor and Chair
Department of Behavioral Sciences & Health Education, Emory University
Christoph Nabholz
Chief Research Officer
Swiss Re Institute
Rodger Novak
President and Chair of the Board of Directors
CRISPR Therapeutics
Florian Rechfeld
Life & Health R&D Manager
Swiss Re Institute
John Schoonbee
Global Chief Medical Officer
Life & Health Products
Thilo Schroeder
Partner
Nextech Invest
Beat Thürlimann
Head of Breast Center
Cantonal Hospital St. Gallen
Thomas Wildhaber
Senior Analyst
Group Finance
Tiffany Zhang
In Force Solutions Manager
Life & Health Business Management